NIH Funds Epoetin Survival Study; CMS Launches ESRD Quality Initiative
Executive Summary
The National Institutes of Health has awarded a two-year grant to explore the causal relationship between the anemia drug epoetin and survival among hemodialysis patients
You may also be interested in...
Aranesp/Procrit Trial Tumor Biopsy Collection Not Feasible, Cmte. Says
Amgen's and Johnson & Johnson's erythropoietin survival studies cannot logistically include a tumor biopsy component, FDA's Oncologic Drugs Advisory Committee said May 4
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials